{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T15:37:52Z","timestamp":1791041872969,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T00:00:00Z","timestamp":1794441600000},"content-version":"am","delay-in-days":346,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22K18377"],"award-info":[{"award-number":["22K18377"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["20K06434"],"award-info":[{"award-number":["20K06434"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["23K05538"],"award-info":[{"award-number":["23K05538"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["24KJ1840"],"award-info":[{"award-number":["24KJ1840"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.dmd.2025.100189","type":"journal-article","created":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T16:54:47Z","timestamp":1761843287000},"page":"100189","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Genetic variants in dog cytochrome P450 2B6 and their relevance to interindividual variability of oxidations of probe drug propofol"],"prefix":"10.1016","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9040-1681","authenticated-orcid":false,"given":"Yasuhiro","family":"Uno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5241-6062","authenticated-orcid":false,"given":"Koya","family":"Fukunaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9232-227X","authenticated-orcid":false,"given":"Genki","family":"Ushirozako","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norie","family":"Murayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6023-3242","authenticated-orcid":false,"given":"Keijiro","family":"Mizukami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomomi","family":"Aoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7708-6218","authenticated-orcid":false,"given":"Hirotaka","family":"Tomiyasu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-8795-6541","authenticated-orcid":false,"given":"Muneki","family":"Honnami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3771-6235","authenticated-orcid":false,"given":"Hajime","family":"Tsujimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Sakaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaharu","family":"Hisasue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taisei","family":"Mushiroda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5638-3504","authenticated-orcid":false,"given":"Yukihide","family":"Momozawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1068-4261","authenticated-orcid":false,"given":"Hiroshi","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dmd.2025.100189_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bcp.2016.06.008","article-title":"Utility of non-human primates in drug development: comparison of non-human primate and human drug-metabolizing cytochrome P450 enzymes","volume":"121","author":"Uno","year":"2016","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.dmd.2025.100189_bib2","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/bs.apha.2022.05.005","article-title":"Polymorphic cytochromes P450 in non-human primates","volume":"95","author":"Uno","year":"2022","journal-title":"Adv Pharmacol"},{"key":"10.1016\/j.dmd.2025.100189_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116124","article-title":"A variety of cytochrome P450 enzymes and flavin-containing monooxygenases in dogs and pigs commonly used as preclinical animal models","volume":"228","author":"Uno","year":"2024","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"10.1016\/j.dmd.2025.100189_bib4","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.pharmthera.2012.12.007","article-title":"Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation","volume":"138","author":"Zanger","year":"2013","journal-title":"Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.dmd.2025.100189_bib5","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.cvsm.2013.05.001","article-title":"Canine cytochrome P-450 pharmacogenetics","volume":"43","author":"Court","year":"2013","journal-title":"Vet Clin North Am Small Anim Pract"},{"issue":"7","key":"10.1016\/j.dmd.2025.100189_bib6","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1080\/00498254.2022.2141153","article-title":"Newly identified tree shrew cytochrome P450 2B6 (CYP2B6) and pig CYP2B6b are functional drug-metabolising enzymes","volume":"52","author":"Uno","year":"2022","journal-title":"Xenobiotica"},{"key":"10.1016\/j.dmd.2025.100189_bib7","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3389\/fgene.2013.00024","article-title":"Pharmacogenetics of cytochrome P450 2B6 (CYP2B6): advances on polymorphisms, mechanisms, and clinical relevance","volume":"4","author":"Zanger","year":"2013","journal-title":"Front Genet"},{"issue":"11","key":"10.1016\/j.dmd.2025.100189_bib8","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1213\/XAA.0000000000000397","article-title":"A case of delayed emergence after propofol anesthesia: genetic analysis","volume":"7","author":"Yonekura","year":"2016","journal-title":"A A Case Rep"},{"issue":"5","key":"10.1016\/j.dmd.2025.100189_bib9","doi-asserted-by":"crossref","first-page":"532","DOI":"10.2133\/dmpk.DMPK-11-RG-039","article-title":"Individual differences in pharmacokinetics and pharmacodynamics of anesthetic agent propofol with regard to CYP2B6 and UGT1A9 genotype and patient age","volume":"26","author":"Kansaku","year":"2011","journal-title":"Drug Metab Pharmacokinet"},{"issue":"1","key":"10.1016\/j.dmd.2025.100189_bib10","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41598-019-56660-z","article-title":"Pharmacogenomics of poor drug metabolism in greyhounds: cytochrome P450 (CYP) 2B11 genetic variation, breed distribution, and functional characterization","volume":"10","author":"Martinez","year":"2020","journal-title":"Sci Rep"},{"issue":"11","key":"10.1016\/j.dmd.2025.100189_bib11","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1097\/00008571-200411000-00008","article-title":"Identification of non-functional allelic variant of CYP1A2 in dogs","volume":"14","author":"Mise","year":"2004","journal-title":"Pharmacogenetics"},{"issue":"2","key":"10.1016\/j.dmd.2025.100189_bib12","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1124\/dmd.32.2.240","article-title":"Polymorphic expression of CYP1A2 leading to interindividual variability in metabolism of a novel benzodiazepine receptor partial inverse agonist in dogs","volume":"32","author":"Mise","year":"2004","journal-title":"Drug Metab Dispos"},{"issue":"9","key":"10.1016\/j.dmd.2025.100189_bib13","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1080\/00498250412331285436","article-title":"Identification of the novel canine CYP1A2 1117 C > T SNP causing protein deletion","volume":"34","author":"Tenmizu","year":"2004","journal-title":"Xenobiotica"},{"issue":"3","key":"10.1016\/j.dmd.2025.100189_bib14","first-page":"278","article-title":"Isolation of a new canine cytochrome P450 CDNA from the cytochrome P450 2C subfamily (CYP2C41) and evidence for polymorphic differences in its expression","volume":"26","author":"Blaisdell","year":"1998","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.dmd.2025.100189_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2021.663175","article-title":"Sequencing of the canine cytochrome P450 CYP2C41 gene and genotyping of its polymorphic occurrence in 36 dog breeds","volume":"8","author":"Karakus","year":"2021","journal-title":"Front Vet Sci"},{"key":"10.1016\/j.dmd.2025.100189_bib16","article-title":"Genotype-first approach revealed unrecognized breed-specific genetic diseases in dogs","author":"Mizukami","year":"2025","journal-title":"bioRxiv"},{"issue":"22","key":"10.1016\/j.dmd.2025.100189_bib17","first-page":"5027","article-title":"Low-frequency coding variants in CETP and CFB are associated with susceptibility of exudative age-related macular degeneration in the Japanese population","volume":"25","author":"Momozawa","year":"2016","journal-title":"Hum Mol Genet"},{"issue":"5","key":"10.1016\/j.dmd.2025.100189_bib18","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/bioinformatics\/btp698","article-title":"Fast and accurate long-read alignment with Burrows-Wheeler transform","volume":"26","author":"Li","year":"2010","journal-title":"Bioinformatics"},{"issue":"9","key":"10.1016\/j.dmd.2025.100189_bib19","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1101\/gr.107524.110","article-title":"The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data","volume":"20","author":"McKenna","year":"2010","journal-title":"Genome Res"},{"key":"10.1016\/j.dmd.2025.100189_bib20","doi-asserted-by":"crossref","DOI":"10.1038\/srep17875","article-title":"Systematic comparison of variant calling pipelines using gold standard personal exome variants","volume":"5","author":"Hwang","year":"2015","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.dmd.2025.100189_bib21","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1124\/dmd.122.001236","article-title":"Novel cytochrome P450 2C94 functionally metabolizes diclofenac and omeprazole in dogs","volume":"51","author":"Uno","year":"2023","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.dmd.2025.100189_bib22","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1016\/S0021-9258(20)82244-3","article-title":"The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature","volume":"239","author":"Omura","year":"1964","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.dmd.2025.100189_bib23","first-page":"265","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J BiolChem"},{"issue":"3","key":"10.1016\/j.dmd.2025.100189_bib24","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1006\/prep.2001.1578","article-title":"Roles of NADPH-P450 reductase and apo- and holo-cytochrome b5 on xenobiotic oxidations catalyzed by 12 recombinant human cytochrome P450s expressed in membranes of Escherichia coli","volume":"24","author":"Yamazaki","year":"2002","journal-title":"Protein Expr Purif"},{"issue":"3","key":"10.1016\/j.dmd.2025.100189_bib25","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1080\/00498254.2018.1439204","article-title":"Marmoset cytochrome P450 2B6, a propofol hydroxylase expressed in liver","volume":"49","author":"Oshio","year":"2019","journal-title":"Xenobiotica"},{"issue":"7","key":"10.1016\/j.dmd.2025.100189_bib26","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1080\/00498250701449431","article-title":"Involvement of human cytochrome P450 2B6 in the omega- and 4-hydroxylation of the anesthetic agent propofol","volume":"37","author":"Murayama","year":"2007","journal-title":"Xenobiotica"},{"issue":"1","key":"10.1016\/j.dmd.2025.100189_bib29","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0021-9258(18)48462-1","article-title":"Substrate recognition sites in cytochrome P450 family 2 (CYP2) proteins inferred from comparative analyses of amino acid and coding nucleotide sequences","volume":"267","author":"Gotoh","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1016\/j.dmd.2025.100189_bib30","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.bcp.2017.12.015","article-title":"Genetic polymorphisms of drug-metabolizing cytochrome P450 enzymes in cynomolgus and rhesus monkeys and common marmosets in preclinical studies for humans","volume":"153","author":"Uno","year":"2018","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"10.1016\/j.dmd.2025.100189_bib31","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1006\/abbi.1998.0801","article-title":"Expression and characterization of canine cytochrome P450 2D15","volume":"357","author":"Roussel","year":"1998","journal-title":"Arch Biochem Biophys"},{"issue":"10","key":"10.1016\/j.dmd.2025.100189_bib32","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/S0090-9556(24)15037-4","article-title":"Evidence for polymorphism in the canine metabolism of the cyclooxygenase 2 inhibitor, celecoxib","volume":"27","author":"Paulson","year":"1999","journal-title":"Drug Metab Dispos"},{"issue":"2","key":"10.1016\/j.dmd.2025.100189_bib33","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/jvp.13113","article-title":"Association of cytochrome P450 2D15 (CYP2D15) nonsynonymous polymorphisms and exon 3 deleted RNA splice variant with CYP2D15 protein content and enzyme function in dog liver microsomes","volume":"46","author":"Jimenez","year":"2023","journal-title":"J Vet Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.dmd.2025.100189_bib34","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1006\/abbi.1996.0022","article-title":"Roles of cytochrome b5 in the oxidation of testosterone and nifedipine by recombinant cytochrome P450 3A4 and by human liver microsomes","volume":"325","author":"Yamazaki","year":"1996","journal-title":"Arch Biochem Biophys"},{"issue":"11","key":"10.1016\/j.dmd.2025.100189_bib35","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1021\/acs.chemrestox.3c00229","article-title":"Oxidation of naringenin, apigenin, and genistein by human family 1 cytochrome P450 enzymes and comparison of interaction of apigenin with human P450 1B1.1 and scutellaria P450 82D.1","volume":"36","author":"Nagayoshi","year":"2023","journal-title":"Chem Res Toxicol"},{"issue":"3","key":"10.1016\/j.dmd.2025.100189_bib36","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S0022-3565(24)35016-5","article-title":"Structure-function analysis of human cytochrome P-450 2B6 using a novel substrate, site-directed mutagenesis, and molecular modeling","volume":"290","author":"Domanski","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"issue":"7","key":"10.1016\/j.dmd.2025.100189_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e28952","article-title":"Genetic variants, haplotype determination, and function of novel alleles of CYP2B6 in a Han Chinese population","volume":"10","author":"Zhang","year":"2024","journal-title":"Heliyon"},{"issue":"1","key":"10.1016\/j.dmd.2025.100189_bib38","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1124\/jpet.104.068973","article-title":"Multiple novel nonsynonymous CYP2B6 gene polymorphisms in Caucasians: demonstration of phenotypic null alleles","volume":"311","author":"Lang","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.dmd.2025.100189_bib39","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.bcp.2018.09.010","article-title":"Functional characterization of 40 CYP2B6 allelic variants by assessing efavirenz 8-hydroxylation","volume":"156","author":"Watanabe","year":"2018","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"10.1016\/j.dmd.2025.100189_bib40","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S0026-895X(25)09688-9","article-title":"Site-directed mutagenesis of putative substrate recognition sites in cytochrome P450 2B11: importance of amino acid residues 114, 290, and 363 for substrate specificity","volume":"46","author":"Hasler","year":"1994","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.dmd.2025.100189_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116515","article-title":"Functional significance of CYP2B6 gene rare allelic variants identified in Japanese individuals","volume":"229","author":"Yamazaki","year":"2024","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"10.1016\/j.dmd.2025.100189_bib42","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/0003-9861(92)90677-O","article-title":"Cytochrome C (Fe2+) as a competitive inhibitor of NADPH-dependent reduction of cytochrome P450 LM2: locating protein-protein interaction sites in microsomal electron carriers","volume":"297","author":"Davydov","year":"1992","journal-title":"Arch Biochem Biophys"},{"issue":"2-3","key":"10.1016\/j.dmd.2025.100189_bib43","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0162-0134(03)00152-1","article-title":"Functional interaction of cytochrome P450 with its redox partners: a critical assessment and update of the topology of predicted contact regions","volume":"96","author":"Hlavica","year":"2003","journal-title":"J Inorg Biochem"},{"issue":"10","key":"10.1016\/j.dmd.2025.100189_bib44","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1124\/dmd.111.040352","article-title":"Functional characterization of CYP2B6 allelic variants in demethylation of antimalarial artemether","volume":"39","author":"Honda","year":"2011","journal-title":"Drug Metab Dispos"},{"issue":"4","key":"10.1016\/j.dmd.2025.100189_bib45","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/86882","article-title":"Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression","volume":"27","author":"Kuehl","year":"2001","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.dmd.2025.100189_bib46","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1124\/mol.62.1.162","article-title":"Co-regulation of CYP3A4 and CYP3A5 and contribution to hepatic and intestinal midazolam metabolism","volume":"62","author":"Lin","year":"2002","journal-title":"Mol Pharmacol"},{"issue":"3","key":"10.1016\/j.dmd.2025.100189_bib47","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.pharmthera.2007.09.004","article-title":"Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects","volume":"116","author":"Ingelman-Sundberg","year":"2007","journal-title":"Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.dmd.2025.100189_bib48","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/s13059-023-03023-7","article-title":"Genome sequencing of 2000 canids by the Dog10K consortium advances the understanding of demography, genome function and architecture","volume":"24","author":"Meadows","year":"2023","journal-title":"Genome Biol"},{"key":"10.1016\/j.dmd.2025.100189_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.dmpk.2025.101496","article-title":"Japanese medicinal drug labeling for use in the clinical setting as informed by pharmacogenomic data on cytochrome P450 enzymes obtained from in silico studies","volume":"64","author":"Tanaka","year":"2025","journal-title":"Drug Metab Pharmacokinet"},{"issue":"7","key":"10.1016\/j.dmd.2025.100189_bib50","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1248\/bpb.b25-00359","article-title":"In silico binary classification of catalytic function (unaffected or impaired) of flavin-containing monooxygenase 3 (FMO3) variants and in vitro validation using new variants found in a Japanese Genome Resource Database","volume":"48","author":"Shimizu","year":"2025","journal-title":"Biol Pharm Bull"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009095562509498X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009095562509498X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T14:58:38Z","timestamp":1777474718000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009095562509498X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":48,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S009095562509498X"],"URL":"https:\/\/doi.org\/10.1016\/j.dmd.2025.100189","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic variants in dog cytochrome P450 2B6 and their relevance to interindividual variability of oxidations of probe drug propofol","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dmd.2025.100189","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Society for Pharmacology and Experimental Therapeutics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"100189"}}